Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-24
2010-02-16
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07662833
ABSTRACT:
The present invention relates to compounds of formula (I). These compounds are a novel type of peptide deformylase (PDF) inhibitors, and are therefore of great interest especially as new antibiotics.
REFERENCES:
patent: 2004/0127719 (2004-07-01), Yang et al.
patent: 0 632 040 (1995-01-01), None
patent: WO 01/85170 (2001-11-01), None
patent: 0230428 (2002-04-01), None
patent: WO 03-101442 (2003-12-01), None
patent: WO 2004/052919 (2004-06-01), None
Kiselyov et al., Tetrahedron Letters (2005), 46(26), 4487-4490.
Ireland et al., Tetrahedron Letters (2003), 44(23), 4369-4371.
Chen et al., Synlett (2001), (8), 1263-1265.
Chen, Jack J. et al., “Multi-Component Synthesis of Imidazo[1,2-a] Annulated Heterocycles on .alpha.-Isocyano Resin Esters”, Synlett, (8)1263-1265(2001). Thieme Stuttgart, New York, NY, US.
Alexander John
Novartis AG
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Imidazo [1,2-A] pyridine derivatives useful as peptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo [1,2-A] pyridine derivatives useful as peptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo [1,2-A] pyridine derivatives useful as peptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168335